The new policy of drug price regulation is postponed to announcement next year
Release time: 2010-11-12 & nbsp & nbsp & nbsp Source:
The "new drug price policy" that has always been concerned by all walks of life will be postponed until next year。This is delayed at least 2 months from the time to the end of October。
As early as mid -October,Reporter learned from stake betting appthe authoritative department,Originally, the basic drug announced prices announced in late October have been temporarily relieved。Previous rumors,Basic drug directory price adjustment may be introduced in late October,Popular drug decrease at 10-20%。
Things Real,The National Development and Reform Commission has conducted special investigations on the factory price of newly entered the national medical insurance directory and some drugs that have stipulated the highest retail price limit (involving more than 900 manufacturers,Nearly 900 varieties),After the survey is over,During the process of soliciting corporate opinions,Some companies have different opinions,As a result, the relevant parties will postponed the announcement of the drug price adjustment document。
According to Song Ruilin, the executive chairman of the China Pharmaceutical Industry Research and Development Promotion Association,Discovered during the survey,Some places are in the centralized bidding of basic drugs,Falling into a strange circle of "low price is stake sports betting appa lifting"。Some small companies have entered the deficiency,Blind price reduction,Even lower than the usual pharmaceutical cost。On the surface,The illusion that the basic drug has a huge price reduction space。
In addition,According to people familiar with the matter,In the future, the country's adjustment of basic medicine prices,I will not just do the price reduction,Pharmaceutical prices higher than the market in the market have room for price reduction,Drug prices that are already lower in market price will not drop anymore,The price of some exclusive varieties will be raised。
Since October,Price adjustment of the new policy has become a "boot that has not landed for a long time" in the market: once it landed,It will impact the profit of pharmaceutical companies,At the same time, the performance on the pharmaceutical sector since October is not unsatisfactory。The latest statistics from Wan De System,The funds of the pharmaceutical sector in October were out of the trend of the capital,Cumulative net outflow reached 9.09 billion My stake betting appyuan。Where,Zixin Pharmaceutical ranked first in the pharmaceutical sector with an increase of 39.72%; Huahai Pharmaceutical ranked first with 16.62%。
This,Industry insiders,Delayed price adjustment policy will not have changed this year's pharmaceutical market。
According to Lin Jianning, Director of the Southern Medical Economics Research Institute of the State Food and Drug Administration,In 2010, the total output value of China's pharmaceutical industry will reach 1256 billion yuan,increased by 25%year -on -year。In 2010, China's pharmaceutical market size will reach 755.6 billion yuan,increased by 22%year -on -year; in 2011, China will be expected to become the third largest pharmaceutical market in the world。
As early as mid -October,Reporter learned from stake betting appthe authoritative department,Originally, the basic drug announced prices announced in late October have been temporarily relieved。Previous rumors,Basic drug directory price adjustment may be introduced in late October,Popular drug decrease at 10-20%。
Things Real,The National Development and Reform Commission has conducted special investigations on the factory price of newly entered the national medical insurance directory and some drugs that have stipulated the highest retail price limit (involving more than 900 manufacturers,Nearly 900 varieties),After the survey is over,During the process of soliciting corporate opinions,Some companies have different opinions,As a result, the relevant parties will postponed the announcement of the drug price adjustment document。
According to Song Ruilin, the executive chairman of the China Pharmaceutical Industry Research and Development Promotion Association,Discovered during the survey,Some places are in the centralized bidding of basic drugs,Falling into a strange circle of "low price is stake sports betting appa lifting"。Some small companies have entered the deficiency,Blind price reduction,Even lower than the usual pharmaceutical cost。On the surface,The illusion that the basic drug has a huge price reduction space。
In addition,According to people familiar with the matter,In the future, the country's adjustment of basic medicine prices,I will not just do the price reduction,Pharmaceutical prices higher than the market in the market have room for price reduction,Drug prices that are already lower in market price will not drop anymore,The price of some exclusive varieties will be raised。
Since October,Price adjustment of the new policy has become a "boot that has not landed for a long time" in the market: once it landed,It will impact the profit of pharmaceutical companies,At the same time, the performance on the pharmaceutical sector since October is not unsatisfactory。The latest statistics from Wan De System,The funds of the pharmaceutical sector in October were out of the trend of the capital,Cumulative net outflow reached 9.09 billion My stake betting appyuan。Where,Zixin Pharmaceutical ranked first in the pharmaceutical sector with an increase of 39.72%; Huahai Pharmaceutical ranked first with 16.62%。
This,Industry insiders,Delayed price adjustment policy will not have changed this year's pharmaceutical market。
According to Lin Jianning, Director of the Southern Medical Economics Research Institute of the State Food and Drug Administration,In 2010, the total output value of China's pharmaceutical industry will reach 1256 billion yuan,increased by 25%year -on -year。In 2010, China's pharmaceutical market size will reach 755.6 billion yuan,increased by 22%year -on -year; in 2011, China will be expected to become the third largest pharmaceutical market in the world。
